{"transactions":[{"id":780094,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":47512,"kind":"person","name":"Campbell Shane Alden","position":1,"cik":"0002068522","reported_name":"Campbell Shane Alden","relationship":{"officer":true,"officer_title":"SVP, Proprietary Segment"}}],"security":"Rst. Stock Unit","published_at":"2026-05-14T20:00:32.000Z","date":"2026-05-12","kind":"exercise","planned":false,"acquired":false,"shares":473.593,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On May 12, 2025, the reporting person was granted 1,891 restricted stock units, vesting in four equal annual installments (plus dividend equivalents)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On May 12, 2025, the reporting person was granted 1,891 restricted stock units, vesting in four equal annual installments (plus dividend equivalents)."}],"balance_after":1417.407,"derivative":{"underlying":"Common Stock","underlying_shares":473.593},"source":{"system":"sec-edgar","filing":"0000105770-26-000075","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000075/form4.xml","form_type":"4"}},{"id":780093,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":47512,"kind":"person","name":"Campbell Shane Alden","position":1,"cik":"0002068522","reported_name":"Campbell Shane Alden","relationship":{"officer":true,"officer_title":"SVP, Proprietary Segment"}}],"security":"Rst. Stock Unit","published_at":"2026-05-14T20:00:32.000Z","date":"2026-05-12","kind":"exercise","planned":false,"acquired":false,"shares":295.995,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On May 12, 2025, the reporting person was granted 1,182 restricted stock units, vesting in four equal annual installments (plus dividend equivalents)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On May 12, 2025, the reporting person was granted 1,182 restricted stock units, vesting in four equal annual installments (plus dividend equivalents)."}],"balance_after":886.005,"derivative":{"underlying":"Common Stock","underlying_shares":295.995},"source":{"system":"sec-edgar","filing":"0000105770-26-000075","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000075/form4.xml","form_type":"4"}},{"id":780092,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":47512,"kind":"person","name":"Campbell Shane Alden","position":1,"cik":"0002068522","reported_name":"Campbell Shane Alden","relationship":{"officer":true,"officer_title":"SVP, Proprietary Segment"}}],"security":"Common Stock","published_at":"2026-05-14T20:00:32.000Z","date":"2026-05-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":134.927,"price":312.07,"value":42106.66889,"ownership":{"direct":true},"balance_after":612.7964,"source":{"system":"sec-edgar","filing":"0000105770-26-000075","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000075/form4.xml","form_type":"4"}},{"id":780091,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":47512,"kind":"person","name":"Campbell Shane Alden","position":1,"cik":"0002068522","reported_name":"Campbell Shane Alden","relationship":{"officer":true,"officer_title":"SVP, Proprietary Segment"}}],"security":"Common Stock","published_at":"2026-05-14T20:00:32.000Z","date":"2026-05-12","kind":"exercise","planned":false,"acquired":true,"shares":473.593,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":747.7234,"source":{"system":"sec-edgar","filing":"0000105770-26-000075","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000075/form4.xml","form_type":"4"}},{"id":780090,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":47512,"kind":"person","name":"Campbell Shane Alden","position":1,"cik":"0002068522","reported_name":"Campbell Shane Alden","relationship":{"officer":true,"officer_title":"SVP, Proprietary Segment"}}],"security":"Common Stock","published_at":"2026-05-14T20:00:32.000Z","date":"2026-05-12","kind":"tax_withholding","planned":false,"acquired":false,"shares":84.329,"price":312.07,"value":26316.55103,"ownership":{"direct":true},"balance_after":274.1304,"source":{"system":"sec-edgar","filing":"0000105770-26-000075","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000075/form4.xml","form_type":"4"}},{"id":780089,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":47512,"kind":"person","name":"Campbell Shane Alden","position":1,"cik":"0002068522","reported_name":"Campbell Shane Alden","relationship":{"officer":true,"officer_title":"SVP, Proprietary Segment"}}],"security":"Common Stock","published_at":"2026-05-14T20:00:32.000Z","date":"2026-05-12","kind":"exercise","planned":false,"acquired":true,"shares":295.995,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":358.4594,"source":{"system":"sec-edgar","filing":"0000105770-26-000075","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000075/form4.xml","form_type":"4"}},{"id":872203,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":47512,"kind":"person","name":"Campbell Shane Alden","position":1,"cik":"0002068522","reported_name":"Campbell Shane Alden","relationship":{"officer":true,"officer_title":"SVP, Proprietary Segment"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-03-03T16:28:56.000Z","date":"2026-03-01","kind":"grant","planned":false,"acquired":true,"shares":2691,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests in four equal annual installments beginning on March 1, 2027."}],"balance_after":2691,"derivative":{"exercise_price":254.34,"expiration_date":"2036-03-01","underlying":"Common Stock","underlying_shares":2691},"source":{"system":"sec-edgar","filing":"0000105770-26-000036","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000036/form4.xml","form_type":"4"}},{"id":872202,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":47512,"kind":"person","name":"Campbell Shane Alden","position":1,"cik":"0002068522","reported_name":"Campbell Shane Alden","relationship":{"officer":true,"officer_title":"SVP, Proprietary Segment"}}],"security":"Rst. Stock Unit","published_at":"2026-03-03T16:28:56.000Z","date":"2026-03-01","kind":"grant","planned":false,"acquired":true,"shares":1131,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of WST common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest in four equal annual installments beginning on March 1, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest in four equal annual installments beginning on March 1, 2027."}],"balance_after":1131,"derivative":{"underlying":"Common Stock","underlying_shares":1131},"source":{"system":"sec-edgar","filing":"0000105770-26-000036","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000010577026000036/form4.xml","form_type":"4"}},{"id":1150134,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":47512,"kind":"person","name":"Campbell Shane Alden","position":1,"cik":"0002068522","reported_name":"Campbell Shane Alden","relationship":{"officer":true,"officer_title":"SVP, Proprietary Segment"}}],"security":"Stock Options (Right to Buy)","published_at":"2025-05-14T20:04:39.000Z","date":"2025-05-12","kind":"grant","planned":false,"acquired":true,"shares":2852,"price":219.46,"value":625899.92,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award vests in four equal annual installments beginning on May 12, 2026."}],"balance_after":2852,"derivative":{"exercise_price":219.46,"exercise_date":"2026-05-12","expiration_date":"2035-05-12","underlying":"Stock Options (Right to Buy)","underlying_shares":2852},"source":{"system":"sec-edgar","filing":"0001127602-25-014250","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/105770/000112760225014250/form4.xml","form_type":"4"}},{"id":1150133,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":47512,"kind":"person","name":"Campbell Shane Alden","position":1,"cik":"0002068522","reported_name":"Campbell Shane Alden","relationship":{"officer":true,"officer_title":"SVP, Proprietary Segment"}}],"security":"Rst. Stock Unit","published_at":"2025-05-14T20:04:39.000Z","date":"2025-05-12","kind":"grant","planned":false,"acquired":true,"shares":1182,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award vests in four equal annual installments beginning on May 12, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"This award vests in four equal annual installments beginning on May 12, 2026."}],"balance_after":1182,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1182},"source":{"system":"sec-edgar","filing":"0001127602-25-014250","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/105770/000112760225014250/form4.xml","form_type":"4"}},{"id":1150132,"issuer":{"id":3201,"kind":"organization","name":"WEST PHARMACEUTICAL SERVICES INC","symbol":"WST"},"owners":[{"id":47512,"kind":"person","name":"Campbell Shane Alden","position":1,"cik":"0002068522","reported_name":"Campbell Shane Alden","relationship":{"officer":true,"officer_title":"SVP, Proprietary Segment"}}],"security":"Rst. Stock Unit","published_at":"2025-05-14T20:04:39.000Z","date":"2025-05-12","kind":"grant","planned":false,"acquired":true,"shares":1891,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This award vests in four equal annual installments beginning on May 12, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"This award vests in four equal annual installments beginning on May 12, 2026."}],"balance_after":1891,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":1891},"source":{"system":"sec-edgar","filing":"0001127602-25-014250","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/105770/000112760225014250/form4.xml","form_type":"4"}}]}